Stocks and Investing
Stocks and Investing
Wed, June 30, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 29, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matt Larew Initiated (TWST) at Buy on, Jun 29th, 2021
Matt Larew of William Blair, Initiated "Twist Bioscience Corporation" (TWST) at Buy on, Jun 29th, 2021.
Matt has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 1 agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Initiated at Hold and Held Target at $110 on, Friday, June 4th, 2021
This is the rating of the analyst that currently disagrees with Matt
- Steven Mah of "Piper Sandler" Initiated at Buy and Held Target at $150 on, Monday, April 12th, 2021
Contributing Sources